Obinutuzumab (Gazyva) is the first drug to be approved for lupus nephritis since the approvals of belimumab (Benlysta) in 2020 and voclosporin (Lupkynis) in 2021.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-third-ever-drug-lupus-nephritis-2025a1000sh4?src=rss
Author :
Publish date : 2025-10-20 19:51:00
Copyright for syndicated content belongs to the linked Source.
